Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-15727.69%
operating margin TTM
-6295.45%
revenue TTM
N/A
revenue per share TTM
0.0$
valuation ratios | |
|---|---|
| pe ratio | -1.11 |
| peg ratio | 0.22 |
| price to book ratio | -1.64 |
| price to sales ratio | 136.07 |
| enterprise value multiple | -1.05 |
| price fair value | -1.64 |
profitability ratios | |
|---|---|
| gross profit margin | 59.5% |
| operating profit margin | -6295.45% |
| pretax profit margin | -15727.69% |
| net profit margin | -15727.69% |
| return on assets | -253.81% |
| return on equity | 138.71% |
| return on capital employed | 59.52% |
liquidity ratios | |
|---|---|
| current ratio | 0.29 |
| quick ratio | 0.29 |
| cash ratio | 0.18 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 360.48 |
| days of payables outstanding | 15,855.15 |
| cash conversion cycle | -15,494.68 |
| receivables turnover | 1.01 |
| payables turnover | 0.02 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.02 |
| debt equity ratio | -0.01 |
| long term debt to capitalization | -0.01 |
| total debt to capitalization | -0.01 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -34.19 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.53 |
| cash per share | 0.32 |
| operating cash flow per share | -0.53 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -34.19 |
| short term coverage ratios | -62.77 |
| capital expenditure coverage ratio | 0.00 |
Frequently Asked Questions
When was the last time NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) reported earnings?
NRx Pharmaceuticals, Inc. (NRXP) published its most recent earnings results on 14-11-2025.
What is NRx Pharmaceuticals, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. NRx Pharmaceuticals, Inc. (NASDAQ:NRXP)'s trailing twelve months ROE is 138.71%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. NRx Pharmaceuticals, Inc. (NRXP) currently has a ROA of -253.81%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did NRXP's net profit margin stand at?
NRXP reported a profit margin of -15727.69% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is NRXP's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 0.29 in the most recent quarter. The quick ratio stood at 0.29, with a Debt/Eq ratio of -0.01.